Unknown

Dataset Information

0

Diacetylbis(N(4)-methylthiosemicarbazonato) copper(II) (CuII(atsm)) protects against peroxynitrite-induced nitrosative damage and prolongs survival in amyotrophic lateral sclerosis mouse model.


ABSTRACT: Amyotrophic lateral sclerosis (ALS) is a progressive paralyzing disease characterized by tissue oxidative damage and motor neuron degeneration. This study investigated the in vivo effect of diacetylbis(N(4)-methylthiosemicarbazonato) copper(II) (CuII(atsm)), which is an orally bioavailable, blood-brain barrier-permeable complex. In vitro the compound inhibits the action of peroxynitrite on Cu,Zn-superoxide dismutase (SOD1) and subsequent nitration of cellular proteins. Oral treatment of transgenic SOD1G93A mice with CuII(atsm) at presymptomatic and symptomatic ages was performed. The mice were examined for improvement in lifespan and motor function, as well as histological and biochemical changes to key disease markers. Systemic treatment of SOD1G93A mice significantly delayed onset of paralysis and prolonged lifespan, even when administered to symptomatic animals. Consistent with the properties of this compound, treated mice had reduced protein nitration and carbonylation, as well as increased antioxidant activity in spinal cord. Treatment also significantly preserved motor neurons and attenuated astrocyte and microglial activation in mice. Furthermore, CuII(atsm) prevented the accumulation of abnormally phosphorylated and fragmented TAR DNA-binding protein-43 (TDP-43) in spinal cord, a protein pivotal to the development of ALS. CuII(atsm) therefore represents a potential new class of neuroprotective agents targeting multiple major disease pathways of motor neurons with therapeutic potential for ALS.

SUBMITTER: Soon CP 

PROVIDER: S-EPMC3243559 | biostudies-literature | 2011 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Diacetylbis(N(4)-methylthiosemicarbazonato) copper(II) (CuII(atsm)) protects against peroxynitrite-induced nitrosative damage and prolongs survival in amyotrophic lateral sclerosis mouse model.

Soon Cynthia P W CPW   Donnelly Paul S PS   Turner Bradley J BJ   Hung Lin W LW   Crouch Peter J PJ   Sherratt Nicki A NA   Tan Jiang-Li JL   Lim Nastasia K-H NK   Lam Linh L   Bica Laura L   Lim SinChun S   Hickey James L JL   Morizzi Julia J   Powell Andrew A   Finkelstein David I DI   Culvenor Janetta G JG   Masters Colin L CL   Duce James J   White Anthony R AR   Barnham Kevin J KJ   Li Qiao-Xin QX  

The Journal of biological chemistry 20111027 51


Amyotrophic lateral sclerosis (ALS) is a progressive paralyzing disease characterized by tissue oxidative damage and motor neuron degeneration. This study investigated the in vivo effect of diacetylbis(N(4)-methylthiosemicarbazonato) copper(II) (CuII(atsm)), which is an orally bioavailable, blood-brain barrier-permeable complex. In vitro the compound inhibits the action of peroxynitrite on Cu,Zn-superoxide dismutase (SOD1) and subsequent nitration of cellular proteins. Oral treatment of transgen  ...[more]

Similar Datasets

2012-07-25 | E-GEOD-39644 | biostudies-arrayexpress
2003-11-14 | GSE833 | GEO
2012-07-26 | GSE39644 | GEO
| S-EPMC2850267 | biostudies-literature
| S-EPMC6137708 | biostudies-literature
| S-EPMC10089700 | biostudies-literature
| S-EPMC2117704 | biostudies-literature
| S-EPMC8039771 | biostudies-literature
| S-EPMC3024775 | biostudies-literature
2010-06-05 | E-GEOD-2400 | biostudies-arrayexpress